Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 9, Issue 11, pp. 1511-1519
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 3, 2019
- Revision received June 3, 2019
- Accepted July 18, 2019
- Published first September 16, 2019.
Article Versions
- Previous version (September 16, 2019 - 12:30).
- Previous version (October 14, 2019 - 05:58).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Maya Kansara1,2,*,
- Kristian Thomson1,
- Puiyi Pang1,
- Aurelie Dutour3,
- Lisa Mirabello4,
- Francine Acher5,
- Jean-Philippe Pin6,
- Elizabeth G. Demicco7,
- Juming Yan8,
- Michele W.L. Teng8,
- Mark J. Smyth9 and
- David M. Thomas1,2,*
- 1The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
- 2St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, New South Wales, Australia.
- 3Cancer Research Center of Lyon, INSERM UMR 1052, CNRS UMR 5286, Centre Leon Berard, Lyon, France.
- 4Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland.
- 5IGF, Universite de Montpellier, CNRS, INSERM, Montpellier, France.
- 6Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, CNRS UMR8601, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
- 7Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
- 8Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
- 9Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
- ↵*Corresponding Authors:
Maya Kansara, Garvan Institute of Medical Research, 370 Victoria Street, Darlinghurst, NSW, Sydney, Australia. Phone: 61-0-2-9355-5779; E-mail: m.kansara{at}garvan.org.au; and David M. Thomas, Phone: 61-0-2-9355-5770; E-mail: d.thomas{at}garvan.org.au
November 2019
Volume 9, Issue 11
Volume 9, Issue 11
Infiltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23
Jump to section
Advertisement